Pfizer and BioNTech’s jointly developed COVID-19 vaccine was successful in neutralizing a new variant of the coronavirus spreading rapidly in Brazil, Reuters reports, citing the findings of a study conducted by scientists from the companies and the University of Texas Medical Branch.
Key takeaways
“Blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil.”
“The neutralizing ability was roughly equivalent to the vaccine’s effect on a previous less contagious version of the virus from last year.”
Previously, Pfizer has said it believes its current vaccine is highly likely to still protect against the South African variant.
Market implications
Encouraging vaccine news combined with the retreat in the US Treasury yields if boding well for the risk sentiment, as the Asian equities attempt a bounce while the S&P 500 futures extend gains towards 3,850.
The US dollar index takes a breather, easing off four-month tops at 92.50.
원저자가 모두 저작권을 보유한 FXStreet에서 재 인쇄 함.
면책 조항: 본 게시글에 표현된 견해는 전적으로 작성자의 견해이며 Followme의 공식 입장을 대변하지 않습니다. Followme는 제공된 정보의 정확성, 완전성 또는 신뢰성에 대해 책임을 지지 않으며, 서면으로 명시적으로 언급되지 않는 한 해당 내용을 기반으로 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다.
더 오래된 의견은 없습니다. 소파를 가장 먼저 잡으십시오.